In contrast to CRABP1, the great majority of breast tumor tissues scored positive for CRABP2, with 90.7 % and 95.4 % of the scored samples showing cytoplasmic and nuclear CRABP2 immunoreactivity, respectively (Fig. 2b and Table 1). The gene discussed is CRABP1; the disease is breast neoplasm.